Sign in

CIK 0001830487

  • Large accelerated filer

Pharvaris N.V.

Sign in to watch
Ticker
PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Other
Phone
+31 712036410
Business address
J.H. OORTWEG 21, 2333 CH LEIDEN, LEIDEN, Netherlands
Former names
Pharvaris, B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,335,217
in 16 filings, $4.1M under 10b5-1 plans

Net −$20,335,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-17 Lesage Anne Chief Early Development Sale −20,000 $38.27 $765K 73,969
2026-09-10 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +30,000 $8.05 $242K 86,450
2026-09-10 Lesage Anne Chief Early Development Sale 10b5-1 −30,000 $38.30 $1.1M 56,450
2026-09-10 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,000 15,000
2026-06-30 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +2,972 $2.59 $8K 61,722
2026-06-30 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +24,900 $8.05 $200K 86,622
2026-06-30 Lesage Anne Chief Early Development Sale 10b5-1 −27,872 $35.48 $989K 58,750
2026-06-30 Lesage Anne Chief Early Development Sale 10b5-1 −30,703 $35.49 $1.1M 93,969
2026-06-30 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −24,900 45,000
2026-06-30 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,972 0
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +1,400 $2.59 $4K 57,850
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +900 $8.05 $7K 58,750
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +4,100 $2.59 $11K 56,450
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion 10b5-1 +4,200 $8.05 $34K 67,050
2026-06-29 Lesage Anne Chief Early Development Sale 10b5-1 −2,300 $35.12 $81K 56,450
2026-06-29 Lesage Anne Chief Early Development Sale 10b5-1 −8,300 $35.05 $291K 58,750
2026-06-29 Lesage Anne Chief Early Development Sale 10b5-1 −6,997 $35.05 $245K 124,672
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,200 69,900
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −1,400 7,072
2026-06-29 Lesage Anne Chief Early Development Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,100 2,972

Page 1 of 3 · 48 trades